InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,505.00
(
-0.71%
)
US TECH 100
19,000.00
(
-0.94%
)
Dow Jones
40,287.53
(
-0.93%
)
Brent Oil
82.28
(
-0.01%
)
Bitcoin
67,781.93
(
-0.55%
)
Post# of 252642
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Mufaso

Send PM Follow Ignore
Followers 32
Posts 487
Boards Moderated 0
Alias Born 01/08/2008

Mufaso

Member Level

Re: mouton29 post# 252589

Sunday, 07/14/2024 9:51:40 AM

Sunday, July 14, 2024 9:51:40 AM

Post# of 252642

I wonder what feedback they received on the question of whether SOL-R design will be accepted as pivotal?


The OCUL study is supposed to last 2.5 years with an enrollment of 825. I would think OCUL would have done something else had the FDA indicated this trial if successful wouldn't be good enough to to file and NDA for approval.

What is your guess on this (i.e. probability)?

"People are best convinced by reasons they discover themselves"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up